Evidence map›Paper›PMID 41749818›Full record

ArticleCancers2026

Ten-Year Experience in the Treatment of Cancers of Unknown Primary from Poland: From Overall Survival to Factors Influencing Response in the Prepersonalization Era.

Konrad Tałasiewicz, Aleksandra Czachowska, Marcin Folwarski, Iwona Ługowska, Dominika Jaxa-Larecka, Aleksandra Kapała

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Konrad TałasiewiczDepartment of Oncology Diagnostics and Palliative Medicine, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw (MSCI), Roentgena 5, 02-781 Warsaw, Poland.ORCID 0000-0001-6575-8005
Aleksandra CzachowskaDepartment of Oncology Diagnostics and Palliative Medicine, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw (MSCI), Roentgena 5, 02-781 Warsaw, Poland.
Marcin FolwarskiDepartment of Clinical Nutrition and Dietetics, Medical University of Gdańsk, Dębinki 7, 80-211 Gdańsk, Poland.ORCID 0000-0002-7301-1689
Iwona ŁugowskaCenter of Excellence in Precision Oncology, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw (MSCI), Roentgena 5, 02-781 Warsaw, Poland.
Dominika Jaxa-LareckaDepartment of Oncology Diagnostics and Palliative Medicine, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw (MSCI), Roentgena 5, 02-781 Warsaw, Poland.
Aleksandra KapałaDepartment of Oncology Diagnostics and Palliative Medicine, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw (MSCI), Roentgena 5, 02-781 Warsaw, Poland.ORCID 0000-0003-4572-6641

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer of unknown primary originNLRprimary cancer of unknown originprognosissurvival

Identifiers

PMID41749818
PMCPMC12938436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.